GSK Tops Pfizer In Number Of Domestic Projects In Japan
This article was originally published in PharmAsia News
Executive Summary
According to a Mix Online survey of 621 development projects by 63 pharmaceutical companies in Japan carried out at the end of April, GSK topped the charts ahead of last year’s leader Pfizer.